It has been previously shown that ALDH1B1 could promote colon cancer tumorigenesis by modulating the Wnt/β-catenin, Notch and PI3K/Akt signaling pathways and might be considered as a selective therapeutic targets to prevent or treat colon cancer [26, 36]. Here, AKT1 is linked to colonic neoplasm.